# Tracking the neurophysiological effects of proteinopathy into the pre-clinical stage of Alzheimer’s disease

**Authors:** Alex I Wiesman, Santiago I Flores-Alonso

PMC · DOI: 10.1093/braincomms/fcaf069 · 2025-02-11

## TL;DR

This paper discusses how early signs of Alzheimer’s disease can be detected through brain activity changes before symptoms appear.

## Contribution

It introduces a new method to track pre-clinical Alzheimer’s using brain signal patterns and connectivity changes.

## Key findings

- Amyloid-β deposition correlates with slower brain oscillations in cognitively healthy adults.
- Functional connectivity in the brain decreases over time in individuals with amyloid-β accumulation.
- These changes can be observed before cognitive decline becomes evident.

## Abstract

This scientific commentary refers to ‘Amyloid-β deposition predicts oscillatory slowing of magnetoencephalography signals and a reduction of functional connectivity over time in cognitively unimpaired adults’, by Scheijbeler et al. (https://doi.org/10.1093/braincomms/fcaf018).

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** proteinopathy (MESH:D057165), Alzheimer's disease (MESH:D000544)

---
Source: https://tomesphere.com/paper/PMC11851007